Literature DB >> 16497595

Errors in interpreting abstinence curves in studies of smoking cessation.

John R Hughes1, Peter W Callas.   

Abstract

Articles on smoking cessation often present curves representing the percentage of smokers still abstinent over time. The purpose of this paper is to illustrate how common conclusions from inspecting these curves may be misleading because they are based on assumptions of which readers are not aware. For example, when active and control abstinence curves converge, this is often interpreted to indicate a diminution of treatment effect size over time. We use illustrative data to show that this interpretation is correct if one assumes a treatment has a constant additive effect; however, if one assumes treatment has a constant multiplicative effect, then converging curves can still indicate a constant treatment effect. Converging abstinence curves are also often interpreted to indicate that the rate of relapse is greater in the active than the control group. We illustrate that this interpretation is correct if one is interested in cumulative relapse rate and uses all subjects in the denominator; however, if one is interested in relapse over a discrete subperiod of time (e.g., immediately after treatment stops), and thus uses only those at risk for relapse, then converging curves can still indicate a constant relapse rate. When trials interpret abstinence curves, they should make clear whether they are assuming additive or multiplicative effects of treatment and are discussing overall or local relapse rates. They should also report both additive and multiplicative effect sizes.

Mesh:

Year:  2006        PMID: 16497595     DOI: 10.1080/14622200500431635

Source DB:  PubMed          Journal:  Nicotine Tob Res        ISSN: 1462-2203            Impact factor:   4.244


  5 in total

Review 1.  Do point prevalence and prolonged abstinence measures produce similar results in smoking cessation studies? A systematic review.

Authors:  John R Hughes; Matthew J Carpenter; Shelly Naud
Journal:  Nicotine Tob Res       Date:  2010-05-26       Impact factor: 4.244

Review 2.  New methods for tobacco dependence treatment research.

Authors:  Timothy B Baker; Robin Mermelstein; Linda M Collins; Megan E Piper; Douglas E Jorenby; Stevens S Smith; Bruce A Christiansen; Tanya R Schlam; Jessica W Cook; Michael C Fiore
Journal:  Ann Behav Med       Date:  2011-04

3.  The effect of five smoking cessation pharmacotherapies on smoking cessation milestones.

Authors:  Sandra J Japuntich; Megan E Piper; Adam M Leventhal; Daniel M Bolt; Timothy B Baker
Journal:  J Consult Clin Psychol       Date:  2011-02

4.  US Nicotine Vaping Product SimSmoke Simulation Model: The Effect of Vaping and Tobacco Control Policies on Smoking Prevalence and Smoking-Attributable Deaths.

Authors:  David T Levy; Luz María Sánchez-Romero; Nargiz Travis; Zhe Yuan; Yameng Li; Sarah Skolnick; Jihyoun Jeon; Jamie Tam; Rafael Meza
Journal:  Int J Environ Res Public Health       Date:  2021-05-03       Impact factor: 4.614

5.  Diminishing benefit of smoking cessation medications during the first year: a meta-analysis of randomized controlled trials.

Authors:  Laura J Rosen; Tal Galili; Jeffrey Kott; Mark Goodman; Laurence S Freedman
Journal:  Addiction       Date:  2018-01-29       Impact factor: 6.526

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.